Macelignan: A New Modulator of P-Glycoprotein in Multidrug-Resistant Cancer Cells

REFERENCES

• Saleem , M , Kim , H J , Ali , M S and Lee , Y S . 2005 . An update on bioactive plant lignans . Nat Prod Rep , 22 : 696 – 716 .
   PubMed Web of Science ®Google Scholar
• Webb , A L and McCullough , M L . 2005 . Dietary lignans: potential role in cancer prevention . Nutr Cancer , 51 : 117 – 131 .
   PubMed Web of Science ®Google Scholar
• Woo , W S , Shin , K H , Wagner , H and Lotter , H . 1987 . The structure of macelignan from Myristica fragrans . Phytochemistry , 26 : 1542 – 1543 .
   Web of Science ®Google Scholar
• Sadhu , S K , Okuyama , E , Fujimoto , H and Ishibashi , M . 2003 . Separation of Leucas aspera, a medicinal plant of Bangladesh, guided by prostaglandin inhibitory and antioxidant activities . Chem Pharm Bull (Tokyo) , 51 : 595 – 598 .
   PubMed Web of Science ®Google Scholar
• Park , B Y , Min , B S , Kwon , O K , Oh , S R Ahn , K S . 2004 . Increase of caspase-3 activity by lignans from Machilus thunbergii in HL-60 cells . Biol Pharm Bull , 27 : 1305 – 1307 .
   PubMed Web of Science ®Google Scholar
• Jin , D Q , Lim , C S , Hwang , J K , Ha , I and Han , J S . 2005 . Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells . Biochem Biophys Res Commun , 331 : 1264 – 1269 .
   PubMedGoogle Scholar
• Chung , J Y , Choo , J H , Lee , M H and Hwang , J K . 2006 . Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans. . Phytomedicine , 13 : 261 – 266 .
   PubMed Web of Science ®Google Scholar
• Wargovich , M J . 1999 . Nutrition and cancer: the herbal revolution . Curr Opin Gastroenterol , 15 : 177 – 180 .
   PubMed Web of Science ®Google Scholar
• Surh , Y J . 2003 . Cancer chemoprevention with dietary phytochemicals . Nat Rev Cancer , 3 : 768 – 780 .
   PubMed Web of Science ®Google Scholar
• Syed , D N , Khan , N , Afaq , F and Mukhtar , H . 2007 . Chemoprevention of prostate cancer through dietary agents: progress and promise . Cancer Epidemiol Biomarkers Prev , 16 : 2193 – 2203 .
   PubMed Web of Science ®Google Scholar
• Gottesman , M M , Fojo , T and Bates , S E . 2002 . Multidrug resistance in cancer: role of ATP-dependent transporters . Nat Rev Cancer , 2 : 48 – 58 .
   PubMed Web of Science ®Google Scholar
• Thomas , H and Coley , H M . 2003 . Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein . Cancer Control , 10 : 159 – 165 .
   PubMedGoogle Scholar
• Boumendjel , A , Di Pietro , A , Dumontet , C and Barron , D . 2002 . Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance . Med Res Rev , 22 : 512 – 529 .
   PubMed Web of Science ®Google Scholar
• Zhang , S and Morris , M E . 2003 . Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport . J Pharmacol Exp Ther , 304 : 1258 – 1267 .
   PubMed Web of Science ®Google Scholar
• Qian , F , Wei , D , Zhang , Q and Yang , S . 2005 . Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells . Biomed Pharmacother , 59 : 64 – 69 .
   PubMed Web of Science ®Google Scholar
• Kitagawa , S . 2006 . Inhibitory effects of polyphenols on p-glycoprotein-mediated transport . Biol Pharm Bull , 29 : 1 – 6 .
   PubMed Web of Science ®Google Scholar
• Wang , Y , Cao , J and Zeng , S . 2005 . Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin . J Pharm Pharmacol , 57 : 751 – 758 .
   PubMed Web of Science ®Google Scholar
• Pan , Q , Lu , Q , Zhang , K and Hu , X . 2006 . Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein . Cancer Chemother Pharmacol , 58 : 99 – 106 .
   PubMed Web of Science ®Google Scholar
• Yoo , H H , Lee , M , Lee , M W , Lim , S Y Shin , J . 2007 . Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 . Planta Med , 73 : 444 – 450 .
   PubMed Web of Science ®Google Scholar
• Carmichael , J , DeGraff , W G , Gazdar , A F , Minna , J D and Mitchell , J B . 1987 . Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing . Cancer Res , 47 : 936 – 942 .
   PubMed Web of Science ®Google Scholar
• Leonard , G D , Fojo , T and Bates , S E . 2003 . The role of ABC transporters in clinical practice . Oncologist , 8 : 411 – 424 .
   PubMed Web of Science ®Google Scholar
• Leonard , G D , Polgar , O and Bates , S E . 2002 . ABC transporters and inhibitors: new targets, new agents . Curr Opin Investig Drugs , 3 : 1652 – 1659 .
   PubMedGoogle Scholar
• Usui , T . 2006 . Pharmaceutical prospects of phytoestrogens . Endocr J , 53 : 7 – 20 .
   PubMed Web of Science ®Google Scholar
• Zhang , S , Yang , X and Morris , M E . 2004 . Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport . Mol Pharmacol , 65 : 1208 – 1216 .
   PubMed Web of Science ®Google Scholar